Antitumor Immunomodulatory Activity of Allogenic Bone Marrow Cells on TiNi Scaffold

被引:0
|
作者
Kokorev, O. V. [1 ]
Hodorenko, V. N. [1 ]
Cherdyntseva, N. V. [2 ]
Gunther, V. E. [1 ]
机构
[1] Tomsk State Univ, Tomsk 634050, Russia
[2] Tomsk Canc Res Inst, Tomsk 634050, Russia
关键词
NITI;
D O I
10.1063/1.4960248
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study was undertaken to evaluate the feasibility of modulation of anti-tumor response by allogenic bone marrow cell transplantation into porous TiNi-based scaffold. Transplantation of bone marrow cells into porous TiNi-based scaffold leads to antitumor (35%) and antimetastatic (55%) effects. The lifetime of tumor-bearing animals and implanted allogenic bone marrow cells in incubator of TiNi increases up to 60%. The possible mechanisms of the effect of allogenic cells on tumor process are the stimulation of endogenous effectors of antitumor immunity.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] BONE-MARROW TRANSPLANTATION - ALLOGENIC OR AUTOLOGOUS
    FERNANDEZRANADA, JM
    REVISTA CLINICA ESPANOLA, 1988, 183 (03): : 105 - 106
  • [32] HUMAN ALLOGENIC BONE-MARROW TRANSPLANTATION
    SYMANN, M
    RODHAIN, J
    HUMBLET, Y
    LOUVAIN MEDICAL, 1977, 96 (03): : 115 - 120
  • [33] Transfusiological aspects of allogenic transplantation of the bone marrow
    Fregatova, LM
    Volkova, OY
    Shavva, SA
    Platonova, GG
    Afanasyev, BV
    TERAPEVTICHESKII ARKHIV, 1998, 70 (07) : 67 - 69
  • [34] ALLOGENIC BONE-MARROW TRANSPLANTATION IN MAN
    DICKE, KA
    LOWENBER.B
    SCHAEFER, UW
    BLUT, 1974, 28 (03): : 210 - 210
  • [35] PREPARATION FOR ALLOGENIC BONE-MARROW GRAFT
    GLUCKMAN, E
    LYON MEDICAL, 1976, 235 (08): : 773 - 773
  • [36] Repair of long-bone pseudoarthrosis with autologous bone marrow mononuclear cells combined with allogenic bone graft
    Fernandez-Bances, Ignacio
    Perez-Basterrechea, Marcos
    Perez-Lopez, Silvia
    Nunez Batalla, Daniel
    Fernandez Rodriguez, Maria Angeles
    Alvarez-Viejo, Maria
    Ferrero-Gutierrez, Amaia
    Menendez-Menendez, Yolanda
    Maria Garcia-Gala, Jose
    Escudero, Dolores
    Paz Aparicio, Jose
    Carnero Lopez, Susana
    Lopez Fernandez, Pedro
    Gonzalez Suarez, Daniel
    Otero Hernandez, Jesus
    CYTOTHERAPY, 2013, 15 (05) : 571 - 577
  • [37] Antitumor activity of the immunomodulatory lead Cumaside
    Aminin, D. L.
    Chaykina, E. L.
    Agafonova, I. G.
    Avilov, S. A.
    Kalinin, V. I.
    Stonik, V. A.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (06) : 648 - 654
  • [38] Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow
    Joshi, SS
    Babushkina-Patz, NN
    Verbik, DJ
    Gross, TG
    Tarantolo, SR
    Kuszynski, CA
    Pirruccello, SJ
    Bishop, MR
    Kessinger, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (04) : 791 - 799
  • [39] HYALURONAN SCAFFOLD SUPPORTS OSTEOGENIC DIFFERENTIATION OF BONE MARROW CONCENTRATE CELLS
    Cavallo, C.
    Desando, G.
    Ferrari, A.
    Zini, N.
    Mariani, E.
    Grigolo, B.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2016, 30 (02): : 409 - 420
  • [40] In vitro chondrogenesis of human bone marrow stem cells on a biodegradable scaffold
    Liu, Kai
    Zhou, Guangdong
    Liu, Tianyi
    Liu, Wei
    Cui, Lei
    Zhang, Wenjie
    Cao, Yilin
    TISSUE ENGINEERING, 2006, 12 (04): : 1012 - 1013